Shinsky Stephen A, Monteith Kelsey E, Viggiano Susan, Cosgrove Michael S
From the Department of Biochemistry and Molecular Biology, State University of New York Upstate Medical University, Syracuse, New York 13210.
From the Department of Biochemistry and Molecular Biology, State University of New York Upstate Medical University, Syracuse, New York 13210
J Biol Chem. 2015 Mar 6;290(10):6361-75. doi: 10.1074/jbc.M114.627646. Epub 2015 Jan 5.
Mixed lineage leukemia protein-1 (MLL1) is a member of the SET1 family of histone H3 lysine 4 (H3K4) methyltransferases that are required for metazoan development. MLL1 is the best characterized human SET1 family member, which includes MLL1-4 and SETd1A/B. MLL1 assembles with WDR5, RBBP5, ASH2L, DPY-30 (WRAD) to form the MLL1 core complex, which is required for H3K4 dimethylation and transcriptional activation. Because all SET1 family proteins interact with WRAD in vivo, it is hypothesized they are regulated by similar mechanisms. However, recent evidence suggests differences among family members that may reflect unique regulatory inputs in the cell. Missing is an understanding of the intrinsic enzymatic activities of different SET1 family complexes under standard conditions. In this investigation, we reconstituted each human SET1 family core complex and compared subunit assembly and enzymatic activities. We found that in the absence of WRAD, all but one SET domain catalyzes at least weak H3K4 monomethylation. In the presence of WRAD, all SET1 family members showed stimulated monomethyltransferase activity but differed in their di- and trimethylation activities. We found that these differences are correlated with evolutionary lineage, suggesting these enzyme complexes have evolved to accomplish unique tasks within metazoan genomes. To understand the structural basis for these differences, we employed a "phylogenetic scanning mutagenesis" assay and identified a cluster of amino acid substitutions that confer a WRAD-dependent gain-of-function dimethylation activity on complexes assembled with the MLL3 or Drosophila trithorax proteins. These results form the basis for understanding how WRAD differentially regulates SET1 family complexes in vivo.
混合谱系白血病蛋白-1(MLL1)是组蛋白H3赖氨酸4(H3K4)甲基转移酶SET1家族的成员,后生动物发育需要该家族成员。MLL1是人类SET1家族中特征最明确的成员,该家族包括MLL1-4和SETd1A/B。MLL1与WDR5、RBBP5、ASH2L、DPY-30(WRAD)组装形成MLL1核心复合物,H3K4二甲基化和转录激活需要该复合物。由于所有SET1家族蛋白在体内都与WRAD相互作用,因此推测它们受相似机制调控。然而,最近的证据表明家族成员之间存在差异,这可能反映了细胞中独特的调控输入。目前尚缺乏对不同SET1家族复合物在标准条件下内在酶活性的了解。在本研究中,我们重组了每个人类SET1家族核心复合物,并比较了亚基组装和酶活性。我们发现,在没有WRAD的情况下,除一个SET结构域外,所有SET结构域至少催化微弱的H3K4单甲基化。在有WRAD的情况下,所有SET1家族成员的单甲基转移酶活性均受到刺激,但二甲基化和三甲基化活性存在差异。我们发现这些差异与进化谱系相关,表明这些酶复合物已经进化以在后生动物基因组中完成独特任务。为了解这些差异的结构基础,我们采用了“系统发育扫描诱变”分析,并鉴定出一组氨基酸取代,这些取代赋予与MLL3或果蝇三体胸蛋白组装的复合物WRAD依赖性功能获得性二甲基化活性。这些结果为理解WRAD如何在体内差异调节SET1家族复合物奠定了基础。